Uterocutaneous fistula managed medically: A case report.
Background: The uterocutaneous fistula is an abnormal connection or passageway between the uterus and the skin. The most common causes include infections, trauma, or surgery, a severe medical condition requiring prompt medical attention and treatment.
Case Presentation: Here, we describe the case of a 36-year-old female who developed a uterocutaneous fistula after cesarean delivery. Her post-cesarean recovery was complicated by wound infection, and after healing the wound, she presented with cyclical bloody discharge from a pinpoint opening in the healed wound scar.
Management: On ultrasound and MRI, she was diagnosed as having a uterocutaneous fistula. She opted for non-surgical management and underwent successful medical management with GnRH agonists. She remained symptom-free after the resumption of her menstrual cycle.
Conclusion: In younger populations hoping to avoid surgery, pharmacological care with GnRH agonist therapy can be a reasonable alternative to surgical resection of the fistulous tract. Healthcare professionals should have a high index of suspicion to diagnose this condition.
2. Gupta SK, Shukla VK, Varma DN, Roy SK. Uterocutaneous fistula. Postgrad med j. 1993;69(816):822-823.
3. Yesiladali M, Saridogan E, Saridogan E. Successful pregnancy and delivery following surgical treatment of postmyomectomy uterocutaneous fistula. BMJ Case Rep CP. 2019;12(12):e231594.
4. Hardy LE, Leung Y. Uterocutaneous fistula as the primary presentation of a gynaecological malignancy. Case Rep. 2018;2018:bcr-2018.
5. Maddah G, Fattahi AS, Rahnama A, Jamshidi ST. Uterocutaneous fistula following cesarean section: successful management of a case. Iran j med sci. 2016;41(2):157-160.
Copyright (c) 2023 The Author
This work is licensed under a Creative Commons Attribution 4.0 International License.